HILLEMAN JERYL L

CIK 000121662812 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001216628

Recent Transactions

50 trades

Award
Omada Health, Inc.$OMDA
Common Stock
2026-01-05+1,601→ 12,794 total
Award
Omada Health, Inc.$OMDA
Common Stock
2025-10-05+1,081→ 11,193 total
Award
Omada Health, Inc.$OMDA
Common Stock
2025-10-05+1,126→ 11,238 total
Disposition from Tender
HilleVax, Inc.
Common Stock
2025-09-17−59,224→ 0 total
Award
Omada Health, Inc.$OMDA
Common Stock
2025-07-05+376→ 10,112 total
Award
HilleVax, Inc.
Common Stock
2025-06-23+17,199→ 59,224 total
Award
SI-BONE, Inc.$SIBN
Common Stock
2025-06-05+8,675→ 32,815 total
Award
Omada Health, Inc.$OMDA
Common Stock
2025-06-05+9,736→ 9,736 total
Award
NovoCure Ltd$NVCR
Ordinary Shares
2025-06-04+11,215→ 16,806 total
Award
NovoCure Ltd$NVCR
Stock Option (Right to Buy)
2025-06-04+16,697→ 16,697 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2025-06-03$17.26/sh−999→ 5,591 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-10-24+14,673→ 40,000 total
Award
CUTERA INC
Stock Option (Right to Buy)
2024-07-12+25,327→ 25,327 total
Award
SI-BONE, Inc.$SIBN
Common Stock
2024-06-26+8,791→ 24,140 total
Award
HilleVax, Inc.
Stock Option
2024-06-06+22,500→ 22,500 total
Award
NovoCure Ltd$NVCR
Stock Option (Right to Buy)
2024-06-05+6,229→ 6,229 total
Award
NovoCure Ltd$NVCR
Restricted Stock Units
2024-06-05+4,053→ 6,590 total
Award
Minerva Neurosciences, Inc.$NERV
Stock Option (right to buy)
2023-09-27+12,500→ 12,500 total
Sale
SI-BONE, Inc.$SIBN
Common Stock
2023-06-20$28.00/sh−2,081→ 15,349 total
Sale
SI-BONE, Inc.$SIBN
Common Stock
2023-06-15$28.74/sh−2,081→ 17,430 total
Award
SI-BONE, Inc.$SIBN
Common Stock
2023-06-09+4,866→ 19,511 total
Award
HilleVax, Inc.
Stock Option
2023-06-07+22,500→ 22,500 total
Award
NovoCure Ltd$NVCR
Stock Option (Right to Buy)
2023-06-07+12,554→ 12,554 total
Award
HilleVax, Inc.
Stock Option
2022-08-19+25,000→ 25,000 total
Award
SI-BONE, Inc.$SIBN
Common Stock
2022-06-16+8,324→ 14,645 total
Sale
SI-BONE, Inc.$SIBN
Common Stock
2022-06-13$13.81/sh−1,924→ 6,321 total
Award
Minerva Neurosciences, Inc.$NERV
Stock Option (right to buy)
2022-06-10+2,500→ 2,500 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-06-10$69.61/sh−407→ 2,537 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2022-06-08+8,700→ 8,700 total
Sale
SI-BONE, Inc.$SIBN
Common Stock
2021-06-25$33.71/sh−4,400→ 8,245 total
Award
Minerva Neurosciences, Inc.$NERV
Stock Option (right to buy)
2021-06-11+20,000→ 20,000 total
Award
SI-BONE, Inc.$SIBN
Common Stock
2021-06-10+3,848→ 12,645 total
Disposition to Issuer
NovoCure Ltd$NVCR
Ordinary Shares
2021-06-09$210.01/sh−1,270→ 2,944 total
Award
NovoCure Ltd$NVCR
Restricted Stock Units
2021-06-09+814→ 4,214 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-06-09+1,499→ 1,499 total
Award
Talis Biomedical Corp$TLIS
Stock Option (right to buy)
2021-03-16+35,112→ 35,112 total
Sale
NovoCure Ltd$NVCR
Restricted Stock Units
2020-12-18$166.40/sh−2,500→ 3,400 total
Award
SI-BONE, Inc.$SIBN
Common Stock
2020-06-16+8,797→ 8,797 total
Award
Minerva Neurosciences, Inc.$NERV
Stock Option (right to buy)
2020-06-11+20,000→ 20,000 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-06-10+5,101→ 5,101 total
Award
NovoCure Ltd$NVCR
Restricted Stock Units
2020-06-10+2,541→ 5,900 total
Award
SI-BONE, Inc.$SIBN
Stock Options (Right to buy)
2019-12-03+26,236→ 26,236 total
Purchase
Minerva Neurosciences, Inc.$NERV
Common Stock
2019-06-26$5.25/sh+1,000→ 1,000 total
Award
Minerva Neurosciences, Inc.$NERV
Stock Option (right to buy)
2019-05-31+20,000→ 20,000 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2019-05-22+6,340→ 6,340 total
Award
NovoCure Ltd$NVCR
Restricted Stock Units
2019-05-22+3,359→ 3,359 total
Award
Intersect ENT, Inc.
Common Stock
2019-05-07+11,952→ 43,836 total
Exercise/Conversion
Intersect ENT, Inc.
Stock Option (right to buy)
2019-04-02−16,491→ 58,509 total
Exercise/Conversion
Intersect ENT, Inc.
Stock Option (right to buy)
2019-04-02−4,709→ 30,625 total
Exercise/Conversion
Intersect ENT, Inc.
Common Stock
2019-04-02$18.90/sh+16,491→ 48,375 total

Companies

Recent Filings

Address

C/O OMADA HEALTH, INC. 611 GATEWAY BLVD., SUITE 120

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov